2025
SJR Q1
JCR Q1 · 4,5
53 matched articles
SCIE
Journal detail
Cytotherapy
- Publisher
- Elsevier B.V.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1465324914772566
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,249
- Quartile Q1
- H-Index 115
- Cites/doc 4,15
- Docs (3y) 449
- Cites (3y) 1.748
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 4,5
- 5Y JIF 4,2
- JCI 0,82
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q2
- Cell Biology Q2
- Genetics (clinical) Q1
- Immunology Q2
- Immunology and Allergy Q2
- Oncology Q1
- Transplantation Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Medicine
WoS categories
- Cell & Tissue Engineering | Biotechnology & Applied Microbiology | Cell Biology | Hematology | Medicine, Research & Experimental
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,249 | 4,5 | 4,2 | 0,82 | Q1 | 115 |
| 2024 | Q1 | Q2 | 1,007 | 3,2 | 3,9 | 0,81 | Q2 | 109 |
| 2023 | Q1 | Q1 | 1,084 | 3,7 | 4,3 | 0,81 | Q2 | 109 |
| 2022 | Q1 | Q2 | 1,186 | 4,5 | 5 | 0,91 | Q1 | 109 |
| 2021 | Q1 | Q1 | 1,004 | 6,2 | 5,8 | 0,92 | Q1 | 109 |
| 2020 | Q1 | Q1 | 1,192 | 5,4 | 5 | 0,98 | Q1 | 109 |
| 2019 | Q1 | Q1 | 1,233 | 4,2 | 4 | 1,04 | Q1 | 109 |
| 2018 | — | Q1 | — | 4,3 | 4,2 | 1,03 | Q1 | — |
| 2017 | Q2 | Q1 | 1,144 | 4 | 3,9 | 0,95 | Q2 | 109 |
| 2016 | Q2 | Q2 | 1,213 | 3,2 | 3,5 | — | — | 109 |
| 2015 | Q1 | Q1 | 1,315 | 3,6 | 3,5 | — | — | 109 |
| 2014 | Q2 | Q2 | 1,193 | 3,3 | 3,3 | — | — | 109 |
| 2013 | Q1 | Q2 | 1,174 | 3,1 | 3,5 | — | — | 109 |
| 2012 | Q2 | Q2 | 1,151 | 3,1 | 3,3 | — | — | 109 |
| 2011 | Q2 | Q1 | 1,158 | 3,6 | 4 | — | — | 109 |
| 2010 | Q2 | Q2 | 0,837 | 2,9 | 3,9 | — | — | 109 |
| 2009 | — | Q2 | — | 2,2 | 3,3 | — | — | — |
| 2008 | — | Q1 | — | 3,5 | 3,3 | — | — | — |
| 2007 | — | Q1 | — | 3,6 | 2,5 | — | — | — |
| 2006 | — | Q2 | — | 2,2 | — | — | — | — |
| 2005 | — | Q2 | — | 1,8 | — | — | — | — |
| 2004 | — | Q2 | — | 1,4 | — | — | — | — |
| 2003 | — | Q3 | — | 0,8 | — | — | — | — |
| 2002 | — | Q3 | — | 0,6 | — | — | — | — |
| 2001 | — | Q3 | — | 1 | — | — | — | — |
| 2000 | — | Q3 | — | 1 | — | — | — | — |
| 1999 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 57/180 |
| 2025 | CELL BIOLOGY | SCIE | Q2 | Q2 | 91/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 14/32 |
| 2025 | HEMATOLOGY | SCIE | Q1 | Q1 | 22/103 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 59/191 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 75/177 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q2 | 111/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 18/32 |
| 2024 | HEMATOLOGY | SCIE | Q2 | Q2 | 29/99 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 84/195 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 54/174 |
| 2023 | CELL BIOLOGY | SCIE | Q2 | Q2 | 99/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 15/31 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q2 | 23/97 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 69/189 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | Q2 | 46/158 |
| 2022 | CELL BIOLOGY | SCIE | Q2 | Q2 | 90/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 12/29 |
| 2022 | HEMATOLOGY | SCIE | Q2 | Q1 | 25/79 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 61/136 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 29/159 |
| 2021 | CELL BIOLOGY | SCIE | Q2 | Q2 | 66/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 10/29 |
| 2021 | HEMATOLOGY | SCIE | Q2 | Q2 | 22/78 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 41/139 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 28/159 |
| 2020 | CELL BIOLOGY | SCIE | Q2 | Q2 | 71/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 13/29 |
| 2020 | HEMATOLOGY | SCIE | Q2 | Q1 | 22/76 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 43/140 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 31/156 |
| 2019 | CELL BIOLOGY | SCIE | Q2 | Q2 | 74/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 12/29 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 19/76 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 40/139 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q1 | 29/162 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q2 | 69/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 7/26 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 18/73 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 37/136 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q2 | 30/161 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 71/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 8/24 |
| 2017 | HEMATOLOGY | SCIE | Q2 | Q2 | 20/71 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | Q2 | 32/133 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 48/160 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 97/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 12/21 |
| 2016 | HEMATOLOGY | SCIE | Q2 | — | 26/70 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 39/128 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 38/161 |
| 2015 | CELL BIOLOGY | SCIE | Q2 | — | 79/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 11/21 |
| 2015 | HEMATOLOGY | SCIE | Q2 | — | 22/70 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 31/124 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 42/163 |
| 2014 | CELL BIOLOGY | SCIE | Q2 | — | 92/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 10/21 |
| 2014 | HEMATOLOGY | SCIE | Q2 | — | 21/68 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 38/123 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 45/165 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 100/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 12/18 |
| 2013 | HEMATOLOGY | SCIE | Q2 | — | 24/68 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 39/124 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 45/160 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 97/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 10/17 |
| 2012 | HEMATOLOGY | SCIE | Q2 | — | 26/67 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 42/121 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 33/158 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 77/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 8/12 |
| 2011 | HEMATOLOGY | SCIE | Q2 | — | 23/68 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 30/112 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 52/160 |
| 2010 | CELL BIOLOGY | SCIE | Q3 | — | 103/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 9/13 |
| 2010 | HEMATOLOGY | SCIE | Q2 | — | 29/66 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 34/106 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 67/152 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 113/162 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q4 | — | 10/12 |
| 2009 | HEMATOLOGY | SCIE | Q3 | — | 37/61 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 42/93 |
| 2008 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 29/144 |
| 2008 | CELL BIOLOGY | SCIE | Q2 | — | 70/157 |
| 2008 | HEMATOLOGY | SCIE | Q2 | — | 20/62 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/83 |
| 2007 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 26/138 |
| 2007 | CELL BIOLOGY | SCIE | Q2 | — | 64/156 |
| 2007 | HEMATOLOGY | SCIE | Q2 | — | 17/63 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/81 |
| 2006 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 53/140 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 101/156 |
| 2006 | HEMATOLOGY | SCIE | Q3 | — | 33/61 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 32/76 |
| 2005 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 62/139 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 106/153 |
| 2005 | HEMATOLOGY | SCIE | Q3 | — | 34/60 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 41/72 |
| 2004 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 64/133 |
| 2004 | CELL BIOLOGY | SCIE | Q4 | — | 117/155 |
| 2004 | HEMATOLOGY | SCIE | Q3 | — | 40/62 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 42/71 |
| 2003 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 86/132 |
| 2003 | CELL BIOLOGY | SCIE | Q4 | — | 136/156 |
| 2003 | HEMATOLOGY | SCIE | Q4 | — | 52/62 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 53/72 |
| 2002 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 92/131 |
| 2002 | CELL BIOLOGY | SCIE | Q4 | — | 138/153 |
| 2002 | HEMATOLOGY | SCIE | Q4 | — | 54/61 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 61/74 |
| 2001 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q3 | — | 66/131 |
| 2001 | CELL BIOLOGY | SCIE | Q4 | — | 120/147 |
| 2001 | HEMATOLOGY | SCIE | Q3 | — | 44/59 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 49/75 |
| 2000 | CELL BIOLOGY | SCIE | Q4 | — | 112/147 |
| 2000 | HEMATOLOGY | SCIE | Q3 | — | 43/60 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 44/74 |
| 1999 | CELL BIOLOGY | SCIE | — | — | — |
| 1999 | HEMATOLOGY | SCIE | — | — | — |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |